Tuesday, November 03, 2020 10:43:50 PM
https://m.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Germany-says-remdesivir-useful-for-some-COVID-19-patients-31681023/
I am sure in the short term Gilead will be announcing a manufacturing deal with a company to mass produce remdesivir. WHO study still has not been peer reviewed. Insurance companies trying to get the price lower and bribing scientists affiliated with WHO? Just maybe! Why is Russia wanting remdesivir as well, since it supposedly has no benefit..
https://m.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Russian-firm-seeks-to-produce-COVID-19-drug-remdesivir-without-patent-31669292/
This drug in combination with remdesivir has shown almost 100% effectiveness. I wonder if they are tryouts no to fast track this...
https://www.globenewswire.com/news-release/2020/09/15/2093822/0/en/Laboratory-Testing-of-Brilacidin-for-COVID-19-in-Combination-with-Remdesivir-Reduces-Viral-Load-by-Nearly-100-Percent.html
“BOOM”
“HOLD ON TIGHT”
-GILD
I am sure in the short term Gilead will be announcing a manufacturing deal with a company to mass produce remdesivir. WHO study still has not been peer reviewed. Insurance companies trying to get the price lower and bribing scientists affiliated with WHO? Just maybe! Why is Russia wanting remdesivir as well, since it supposedly has no benefit..
https://m.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Russian-firm-seeks-to-produce-COVID-19-drug-remdesivir-without-patent-31669292/
This drug in combination with remdesivir has shown almost 100% effectiveness. I wonder if they are tryouts no to fast track this...
https://www.globenewswire.com/news-release/2020/09/15/2093822/0/en/Laboratory-Testing-of-Brilacidin-for-COVID-19-in-Combination-with-Remdesivir-Reduces-Viral-Load-by-Nearly-100-Percent.html
“BOOM”
“HOLD ON TIGHT”
-GILD
If I am posting on a company’s message board, I more than likely have a position with said company. Everything I post is in my opinion. Go Seahawks!
Recent GILD News
- Tempus AI Shares Gain After Expanded Partnership with Gilead • IH Market News • 04/10/2026 01:34:23 PM
- Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline • Business Wire • 04/07/2026 12:30:00 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 04/01/2026 08:34:18 PM
- Gilead Extends Tender Offer to Acquire Arcellx • Business Wire • 04/01/2026 08:13:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/30/2026 09:59:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/27/2026 08:03:17 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/26/2026 10:40:06 PM
- Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases • Business Wire • 03/23/2026 10:15:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/20/2026 08:01:13 PM
- Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care • PR Newswire (US) • 03/19/2026 02:00:00 PM
- Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care • PR Newswire (Canada) • 03/19/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 10:56:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 10:14:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:06:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:45:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:42:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:37:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:24:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:22:25 PM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 03/06/2026 09:55:42 PM
- Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion • PR Newswire (Canada) • 03/03/2026 02:00:00 PM
- Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 09:54:14 PM
